Galapagos completes recruitment of PINTA trial in idiopathic pulmonary fibrosis

NEXT STORY
KaNDy Therapeutics Announces Positive Phase 2b Data in Post-Menopausal Women with its Lead Non-Hormonal Product NT-814
PREV STORY
Guardant Health and NRG Oncology Initiate Randomized Trial to Investigate Circulating Tumor DNA Guided Adjuvant Therapy in Stage II Colon Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cancer Genetics, Inc. Acclaimed by Frost & Sullivan For North American Technology Innovation in Precision Oncology

RUTHERFORD, N.J. and LOS ANGELES, July 27, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. ...

author_avatar
NASDAQ Market News

Radius Health Reports First Quarter 2018 Financial and Operating Results and Provides Business Update

First quarter 2018 TYMLOS® sales increase to $14.5 million, a 90% increase over the fourth ...

author_avatar
NASDAQ Market News

Emergent BioSolutions Presents Preclinical Data on ES425 a Bispecific Immunotherapeutic Protein for Triple-Negative Breast Cancer

GAITHERSBURG, Md., April 20, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced ...

author_avatar
NASDAQ Market News